Pulsipher, M A <br/><br/>
Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?  [electronic resource] 

 -  Bone marrow transplantation  Sep 2015 
 - 1173-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/bmt.2015.103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Allografts<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--blood<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Infant<br/>Male<br/>Neoplasm, Residual<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--blood<br/>Recurrence<br/>Survival Rate<br/>Time Factors